Kaczmarczyk; Stanislaw J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kaczmarczyk; Stanislaw J..The latest application filed is for "cancer immunotherapy by delivering class ii mhc antigens using a vlp-replicon".
- Kaczmarczyk; Stanislaw J. - Frederick MD
- Kaczmarczyk; Stanislaw J - Frederick MD
| Patent | Date |
|---|---|
| Cancer Immunotherapy By Delivering Class Ii Mhc Antigens Using A Vlp-replicon App 20210163988 - Chatterjee; Deb K. ; et al. | 2021-06-03 |
| Delivery Of Packaged Rna To Mammalian Cells App 20200102545 - Kaczmarczyk; Stanislaw J. ; et al. | 2020-04-02 |
| Delivery of packaged RNA to mammalian cells Grant 10,538,743 - Kaczmarczyk , et al. Ja | 2020-01-21 |
| Delivery of packaged RNA to mammalian cells Grant 9,506,041 - Kaczmarczyk , et al. November 29, 2 | 2016-11-29 |
| Delivery Of Packaged Rna To Mammalian Cells App 20160340653 - Kaczmarczyk; Stanislaw J. ; et al. | 2016-11-24 |
| Cancer Immunotherapy By Delivering Class Ii Mhc Antigens Using A Vlp-replicon App 20160312242 - CHATTERJEE; Deb K. ; et al. | 2016-10-27 |
| Delivery Of Packaged Rna To Mammalian Cells App 20150050243 - Kaczmarczyk; Stanislaw J. ; et al. | 2015-02-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 